Partners

Concerto HealthAI has an exclusive, 10-year license with ASCO’s CancerLinQ. Our collective RWD solutions now have over 2M patient records, with scheduled future growth.

2
MILLION
PATIENTS
600
MEDICAL
ONCOLOGISTS
175+
U.S. SITES
80/20
COMMUNITY-TO-
ACADEMIC RATIO

Our RWD support key research programs of ASCO and the FDA, advancing the industry’s confidence in and expanding the use cases of real-world evidence.

Six presentations at the 2019 ASCO Annual Meeting utilized Concerto HealthAI data and technology products based on ASCO's CancerLinQ Discovery® Database.

Read the ASCO 2019 Abstracts

Become a Partner